Globeflex Capital »

Halozyme Therapeutics shares owned by Globeflex Capital

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Globeflex Capital from 13F filings

Historical chart of Globeflex Capital investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Globeflex Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Globeflex Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $992k 26k 38.20
2023-06-30 $829k 23k 36.07
2023-03-31 $878k 23k 38.19
2022-12-31 $1.3M 23k 56.90
2022-09-30 $1.5M 38k 39.55
2022-06-30 $1.8M 40k 43.99
2022-03-31 $2.2M 55k 39.88
2021-12-31 $2.2M 55k 40.21
2021-09-30 $108k 2.6k 40.86
2020-06-30 $496k 19k 26.82
2016-12-31 $883k 89k 9.88
2016-09-30 $1.1M 89k 12.08
2016-06-30 $771k 89k 8.63
2016-03-31 $1.2M 127k 9.47
2015-12-31 $109k 6.3k 17.30
2015-09-30 $681k 51k 13.43
2015-06-30 $1.2M 53k 22.58